Je-Jung Lee, M.D.
Korean J Hematol 2010; 45(3): 143-144Vladia Monsurró, Ph.D.
Korean J Hematol 2010; 45(3): 145-146Young Ae Lim, M.D.
Korean J Hematol 2010; 45(3): 147-149Choong-Hwan Cha, and Jeong Uk Kim
Korean J Hematol 2010; 45(3): 150Ki Hwan Kim, and Ho Young Lee
Korean J Hematol 2010; 45(3): 151Mark H. Yazer
Korean J Hematol 2010; 45(3): 152-157Yeon-Joo Yook, Young-Jin Seo, Hyoung Jin Kang, Sang-Hyeok Ko, Hee Young Shin, Jeong Jin Lee, Gajin Jeong, and Hyo Seop Ahn
Korean J Hematol 2010; 45(3): 158-163Kyung Nam Koh, Meerim Park, Bo Eun Kim, Ho Joon Im, and Jong Jin Seo
Korean J Hematol 2010; 45(3): 164-170Won Kyung Kwon, Jin Young Lee, Yeung Chul Mun, Chu Myong Seong, Wha Soon Chung, and Jungwon Huh
Korean J Hematol 2010; 45(3): 171-176Hyoeun Shim, Hyun-Sook Chi, Seongsoo Jang, Eul-Ju Seo, Chan-Jeoung Park, Jung-Hee Lee, Je-Hwan Lee, and Kyoo-Hyung Lee
Korean J Hematol 2010; 45(3): 177-182
Mixed lineage AML (Case No. 7).
Therapy-related myeloid neoplasm (Case No. 3).
Event-free survival plot of 11q23 group vs. non-11q23 group, showing significantly poorer survival of the 11q23 translocated group (